catecholamine COMT MAO
Selected indexed studies
- Clinical benefit of MAO-B and COMT inhibition in Parkinson's disease: practical considerations. (J Neural Transm (Vienna), 2023) [PMID:36964457]
- Pharmacological Treatment of Tremor in Parkinson's Disease Revisited. (J Parkinsons Dis, 2023) [PMID:36847017]
- Parkinson's Disease: A Review from Pathophysiology to Treatment. (Mini Rev Med Chem, 2020) [PMID:31686637]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Pharmacological Treatment of Tremor in Parkinson's Disease Revisited. (2023) pubmed
- Clinical benefit of MAO-B and COMT inhibition in Parkinson's disease: practical considerations. (2023) pubmed
- Parkinson's Disease: A Review from Pathophysiology to Treatment. (2020) pubmed
- [(11)C]meta-Hydroxyephedrine. (2004) pubmed
- [(11)C]Norepinephrine. (2004) pubmed
- Association of COMT rs4680 and MAO-B rs1799836 polymorphisms with levodopa-induced dyskinesia in Parkinson's disease-a meta-analysis. (2021) pubmed
- MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease. (2018) pubmed
- [The role of inhibitors of COMT and MAO-B in the therapy of Parkinson's disease]. (2020) pubmed
- Inhibitors of MAO-B and COMT: their effects on brain dopamine levels and uses in Parkinson's disease. (2019) pubmed
- Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Parkinson's Disease: Real-World Short-Term Data on Tolerability, Infusion Rate Adjustments and Concomitant Medication. (2025) pubmed